These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2078995)

  • 1. Potassium channel openers. Pharmacological effects and future uses.
    Duty S; Weston AH
    Drugs; 1990 Dec; 40(6):785-91. PubMed ID: 2078995
    [No Abstract]   [Full Text] [Related]  

  • 2. Potassium channel openers exhibit cross-tolerance with morphine in two experimental models of pain.
    Khanna N; Malhotra RS; Mehta AK; Garg GR; Halder S; Sharma KK
    West Indian Med J; 2010 Oct; 59(5):473-8. PubMed ID: 21473392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New activators of potassium channels: design, pharmacology and therapeutic perspectives].
    Pirotte B; Fontaine J; Lebrun P
    J Pharm Belg; 1995; 50(2-3):167-78. PubMed ID: 7674116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potassium channel openers as potential therapeutic weapons in ion channel disease.
    Lawson K
    Kidney Int; 2000 Mar; 57(3):838-45. PubMed ID: 10720937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potassium channel openers induce mitochondrial matrix volume changes via activation of ATP-sensitive K+ channel.
    Szewczyk A; Mikołajek B; Pikuła S; Nałecz MJ
    Pol J Pharmacol; 1993; 45(4):437-43. PubMed ID: 8118486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: a common mechanism of action?
    Welch SP; Dunlow LD
    J Pharmacol Exp Ther; 1993 Oct; 267(1):390-9. PubMed ID: 8229767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. K(+)-channel openers: new antihypertensive drugs?
    Haeusler G
    Clin Physiol Biochem; 1990; 8 Suppl 2():46-56. PubMed ID: 2095310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potassium channel openers: effects on the vascular system.
    Weston AH
    Jpn J Pharmacol; 1992; 58 Suppl 2():232P-237P. PubMed ID: 1507539
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of inhibitors and activators of ATP-regulated K+ channel on mitochondrial potassium uniport.
    Szewczyk A; Pikuła S; Nałecz MJ
    Biochem Mol Biol Int; 1996 Mar; 38(3):477-84. PubMed ID: 8829606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ion channels of vascular smooth muscle and pharmacological effects of calcium antagonists and potassium channel openers].
    Kitamura K; Ogata R
    Fukuoka Igaku Zasshi; 1994 Nov; 85(11):309-13. PubMed ID: 7851831
    [No Abstract]   [Full Text] [Related]  

  • 11. 4-morpholinecarboximidine-N-1-adamantyl-N'-cyclohexylhydrochloride (U-37883A): pharmacological characterization of a novel antagonist of vascular ATP-sensitive K+ channel openers.
    Meisheri KD; Humphrey SJ; Khan SA; Cipkus-Dubray LA; Smith MP; Jones AW
    J Pharmacol Exp Ther; 1993 Aug; 266(2):655-65. PubMed ID: 8355199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia.
    Grover GJ
    J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S18-27. PubMed ID: 7898104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding and effect of K ATP channel openers in the absence of Mg2+.
    Russ U; Lange U; Löffler-Walz C; Hambrock A; Quast U
    Br J Pharmacol; 2003 May; 139(2):368-80. PubMed ID: 12770942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchodilator and tracheal relaxant effects of potassium channel openers in the guinea-pig.
    De Souza RN; Gater PR; Alabaster VA
    Br J Pharmacol; 1989 Dec; 98 Suppl():803P. PubMed ID: 2611517
    [No Abstract]   [Full Text] [Related]  

  • 15. Potassium channel openers: airway pharmacology and clinical possibilities in asthma.
    Raeburn D; Karlsson JA
    Prog Drug Res; 1991; 37():161-80. PubMed ID: 1763182
    [No Abstract]   [Full Text] [Related]  

  • 16. Possible antipruritic effects of K+ channel openers in mice.
    Takano N; Arai I; Kurachi M
    J Dermatol Sci; 2004 Jun; 35(1):71-3. PubMed ID: 15194151
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of morphine and potassium channel openers on experimental models of pain in mice.
    Khanna N; Malhotra RS; Mehta AK; Garg GR; Halder S; Sharma KK
    Fundam Clin Pharmacol; 2011 Aug; 25(4):479-84. PubMed ID: 20880384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guide to the Pharmacology of Mitochondrial Potassium Channels.
    Augustynek B; Kunz WS; Szewczyk A
    Handb Exp Pharmacol; 2017; 240():103-127. PubMed ID: 27838853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of action of various ATP-sensitive potassium channel openers.
    Grover GJ
    Cardiovasc Res; 1996 Jan; 31(1):177-9. PubMed ID: 8849605
    [No Abstract]   [Full Text] [Related]  

  • 20. Moving together: K+ channel openers and ATP-sensitive K+ channels.
    Quast U; Cook NS
    Trends Pharmacol Sci; 1989 Nov; 10(11):431-5. PubMed ID: 2692253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.